Manmeet S Ahluwalia

Trials

Studies that name Manmeet S Ahluwalia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:37 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05756985 · Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

  Baptist Health South Florida · recruiting · Glioblastoma, Glioblastoma Multiforme, Gliosarcoma · principal investigator
• Ph2
  NCT05163080 · SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)

  MimiVax, LLC · unknown · Newly Diagnosed Glioblastoma · principal investigator
• Ph2/Ph3
  NCT04105374 · Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

  NRG Oncology · withdrawn · Anaplastic Astrocytoma, Glioblastoma, Oligodendroglioma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• NRG Oncology Network Group Operations Center
  U10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026
  Named on NCT04105374